CN105169233A - Traditional Chinese medicine composition for treating calculi - Google Patents
Traditional Chinese medicine composition for treating calculi Download PDFInfo
- Publication number
- CN105169233A CN105169233A CN201510536579.8A CN201510536579A CN105169233A CN 105169233 A CN105169233 A CN 105169233A CN 201510536579 A CN201510536579 A CN 201510536579A CN 105169233 A CN105169233 A CN 105169233A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- chinese medicine
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating calculi. The traditional Chinese medicine composition comprises, by weight, 12 parts of roots of Chinese thorowax, 12 parts of red peony roots, 12 parts of immature bitter orange, 24 parts of capillary wormwood herb, 12 parts of baical skullcap roots, 10 parts of roots of red-rooted salvia, 10 parts of rhubarb, 12 parts of turmeric root-tuber, 15 parts of common andrographis herb, 30 parts of herba lysimachiae, 10 parts of cape jasmine fruit, 12 parts of chicken's gizzard-membrane, 10 parts of costustoot, 10 parts of turmeric, 10 parts of dried tangerine peel, 15 parts of lygodium spores, 15 parts of grassleaf sweelflag rhizomes, 10 parts of beautiful sweetgum fruit, 15 parts of plantain seeds, 10 parts of talc, 15 parts of pink herb, 20 parts of cowherb seeds, 10 parts of rhizoma corydalis, 12 parts of twotooth achyranthes roots, 15 parts of white peony roots, 15 parts of pyrrosia leaves, 20 parts of chingma abutilon seeds, 15 parts of yellow croaker ear-stone, 15 parts of fructus aurantii and 10 parts of liquorice. The traditional Chinese medicine composition prepared from natural traditional Chinese medicine raw materials is wide in medicine source, low in cost, simple to prepare, little in toxic or side effect and remarkable in treatment effect.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of Chinese medicine composition for the treatment of calculus.
Background technology
Urinary system calculus is common, the sick frequently-occurring disease of urinary system.Calculus is found in any position of kidney, bladder, ureter and urethra.But be common with kidney and ureteral calculus.Clinical manifestation has different because position, calculus place is different.The typical performance of kidney and ureteral calculus is renal colic and hematuria, before calculus causes angor to show effect, patient is without any sensation, due to certain inducement, as strenuous exercise, work, long-distancely to ride, suddenly there is the angor that side waist is violent, and to lower abdomen and perineal position radiation, with abdominal distention, Nausea and vomiting, hematuria that degree is different; Vesical calculus main manifestations is dysuria and urodynamic.
Urinary system calculus belongs to traditional Chinese medical science stranguria dne to urolithiasis category, its time umbilicus abdomen in dull pain, difficulty in urination, its unbearably painful person.Its etiology and pathogenesis for suffering from a deficiency of the kidney, damp and hot, person who suffer from deficiency of kidney Yang functioning of bladder is unfavorable, urinary function is not normal, damp and hot accumulates the long-pending part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels, urine decocts by it, and in urine, impurity forms sandstone.Current western medical treatment effect is also undesirable, and its means are mainly with surgical calculus removing, blast wave stone-breaking etc., but contraindication is many, and operation wound is large, and relapse rate is high, and expense is also high, allows patient suffer untold misery.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of calculus.
In order to realize object of the present invention, the invention provides a kind of Chinese medicine composition for the treatment of calculus, it comprises the material of following weight portion: Radix Bupleuri 12 parts, Radix Paeoniae Rubra 12 parts, Fructus Aurantii Immaturus 12 parts, Herba Artemisiae Scopariae 24 parts, Radix Scutellariae 12 parts, Radix Salviae Miltiorrhizae 10 parts, Radix Et Rhizoma Rhei 10 parts, Radix Curcumae 12 parts, Herba Andrographis 15 parts, Herba Lysimachiae 30 parts, Fructus Gardeniae 10 parts, Endothelium Corneum Gigeriae Galli 12 parts, the Radix Aucklandiae 10 parts, 10 parts, Rhizoma Curcumae Longae, Pericarpium Citri Reticulatae 10 parts, Spora Lygodii 15 parts, Rhizoma Acori Graminei 15 parts, Fructus Liquidambaris 10 parts, Semen Plantaginis 15 parts, 10 parts, Talcum, Herba Dianthi 15 parts, Semen Vaccariae 20 parts, Rhizoma Corydalis 10 parts, Radix Achyranthis Bidentatae 12 parts, the Radix Paeoniae Alba 15 parts, Folium Pyrrosiae 15 parts, Semen Abutili 20 parts, Asteriscus Pseudosciaenae 15 parts, Fructus Aurantii 15 parts and 10 parts, Radix Glycyrrhizae.
Preferably, the Chinese medicine composition for the treatment of calculus of the present invention also comprises the material of following weight portion: Mahonia fortunei (Lindl.) Fedde 12 parts, the Radix Pulsatillae 18 parts, Cortex Alni sibiricae 15 parts, Amur Adonis Herb 12 parts, Herba malachii aquatici 13 parts, Herba Lysimachiae Insignis 15 parts, Herba Haloragidis Micranthae 10 parts, Caulis Bauhihiae Championii 10 parts, Radix Bauhiniae Hupehanae 10 parts, Herba oxalidis corymbosae 12 parts, Radix Phyllagathis fordii 12 parts and Rhizoma Tupistrae Chinensis 10 parts.
More preferably, described Chinese medicine composition can be tablet, dispersible tablet, capsule, unguentum or decoction.
The present invention also provides the purposes of compositions in the Chinese medicine of preparation treatment calculus, described compositions comprises the material of following weight portion: Radix Bupleuri 12 parts, Radix Paeoniae Rubra 12 parts, Fructus Aurantii Immaturus 12 parts, Herba Artemisiae Scopariae 24 parts, Radix Scutellariae 12 parts, Radix Salviae Miltiorrhizae 10 parts, Radix Et Rhizoma Rhei 10 parts, Radix Curcumae 12 parts, Herba Andrographis 15 parts, Herba Lysimachiae 30 parts, Fructus Gardeniae 10 parts, Endothelium Corneum Gigeriae Galli 12 parts, the Radix Aucklandiae 10 parts, 10 parts, Rhizoma Curcumae Longae, Pericarpium Citri Reticulatae 10 parts, Spora Lygodii 15 parts, Rhizoma Acori Graminei 15 parts, Fructus Liquidambaris 10 parts, Semen Plantaginis 15 parts, 10 parts, Talcum, Herba Dianthi 15 parts, Semen Vaccariae 20 parts, Rhizoma Corydalis 10 parts, Radix Achyranthis Bidentatae 12 parts, the Radix Paeoniae Alba 15 parts, Folium Pyrrosiae 15 parts, Semen Abutili 20 parts, Asteriscus Pseudosciaenae 15 parts, Fructus Aurantii 15 parts and 10 parts, Radix Glycyrrhizae.
Preferably, described compositions also comprises the material of following weight portion: Mahonia fortunei (Lindl.) Fedde 12 parts, the Radix Pulsatillae 18 parts, Cortex Alni sibiricae 15 parts, Amur Adonis Herb 12 parts, Herba malachii aquatici 13 parts, Herba Lysimachiae Insignis 15 parts, Herba Haloragidis Micranthae 10 parts, Caulis Bauhihiae Championii 10 parts, Radix Bauhiniae Hupehanae 10 parts, Herba oxalidis corymbosae 12 parts, Radix Phyllagathis fordii 12 parts and Rhizoma Tupistrae Chinensis 10 parts.
More preferably, described Chinese medicine can be tablet, dispersible tablet, capsule, unguentum or decoction.
Chinese medicine composition of the present invention interacts, and synergism is evident in efficacy, highly widelys popularize.
Detailed description of the invention
The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustration of the present invention instead of limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Unless otherwise stated, the percent in the present invention is percetage by weight.
Embodiment 1 decoction of the present invention
Take Radix Bupleuri 12 grams, Radix Paeoniae Rubra 12 grams, Fructus Aurantii Immaturus 12 grams, Herba Artemisiae Scopariae 24 grams, Radix Scutellariae 12 grams, Radix Salviae Miltiorrhizae 10 grams, Radix Et Rhizoma Rhei 10 grams, Radix Curcumae 12 grams, Herba Andrographis 15 grams, Herba Lysimachiae 30 grams, Fructus Gardeniae 10 grams, Endothelium Corneum Gigeriae Galli 12 grams, the Radix Aucklandiae 10 grams, 10 grams, Rhizoma Curcumae Longae, Pericarpium Citri Reticulatae 10 grams, Spora Lygodii 15 grams, Rhizoma Acori Graminei 15 grams, Fructus Liquidambaris 10 grams, Semen Plantaginis 15 grams, 10 grams, Talcum, Herba Dianthi 15 grams, Semen Vaccariae 20 grams, Rhizoma Corydalis 10 grams, Radix Achyranthis Bidentatae 12 grams, the Radix Paeoniae Alba 15 grams, Folium Pyrrosiae 15 grams, Semen Abutili 20 grams, Asteriscus Pseudosciaenae 15 grams, Fructus Aurantii 15 grams and 10 grams, Radix Glycyrrhizae, add 6000 ml waters, reflux 5 hours in the flask that condensing tube is housed, then filter, obtain filtrate 1 and filtering residue 1, 2) in filtering residue 1, add 3000 ml waters, heat 3 hours in the flask that condensing tube is housed, filter, obtain filtrate 2 and filtering residue 2, 3) merge described filtrate 1, filtrate 2, be concentrated into 3000 milliliters, be cooled to room temperature, to obtain final product.
Embodiment 2 decoction of the present invention
Take Radix Bupleuri 12 grams, Radix Paeoniae Rubra 12 grams, Fructus Aurantii Immaturus 12 grams, Herba Artemisiae Scopariae 24 grams, Radix Scutellariae 12 grams, Radix Salviae Miltiorrhizae 10 grams, Radix Et Rhizoma Rhei 10 grams, Radix Curcumae 12 grams, Herba Andrographis 15 grams, Herba Lysimachiae 30 grams, Fructus Gardeniae 10 grams, Endothelium Corneum Gigeriae Galli 12 grams, the Radix Aucklandiae 10 grams, 10 grams, Rhizoma Curcumae Longae, Pericarpium Citri Reticulatae 10 grams, Spora Lygodii 15 grams, Rhizoma Acori Graminei 15 grams, Fructus Liquidambaris 10 grams, Semen Plantaginis 15 grams, 10 grams, Talcum, Herba Dianthi 15 grams, Semen Vaccariae 20 grams, Rhizoma Corydalis 10 grams, Radix Achyranthis Bidentatae 12 grams, the Radix Paeoniae Alba 15 grams, Folium Pyrrosiae 15 grams, Semen Abutili 20 grams, Asteriscus Pseudosciaenae 15 grams, Fructus Aurantii 15 grams, 10 grams, Radix Glycyrrhizae, Mahonia fortunei (Lindl.) Fedde 12 grams, the Radix Pulsatillae 18 grams, Cortex Alni sibiricae 15 grams, Amur Adonis Herb 12 grams, Herba malachii aquatici 13 grams, Herba Lysimachiae Insignis 15 grams, Herba Haloragidis Micranthae 10 grams, Caulis Bauhihiae Championii 10 grams, Radix Bauhiniae Hupehanae 10 grams, Herba oxalidis corymbosae 12 grams, Radix Phyllagathis fordii 12 grams and Rhizoma Tupistrae Chinensis 10 grams, add 6000 ml waters, reflux 5 hours in the flask that condensing tube is housed, then filter, obtain filtrate 1 and filtering residue 1, 2) in filtering residue 1, add 3000 ml waters, heat 3 hours in the flask that condensing tube is housed, filter, obtain filtrate 2 and filtering residue 2, 3) merge described filtrate 1, filtrate 2, be concentrated into 3000 milliliters, be cooled to room temperature, to obtain final product.
Experimental example
Diagnostic criteria
With " Chinese medical disease Standardization of diagnosis and curative effect " be with reference to (State Administration of Traditional Chinese Medicine. Chinese medical disease Standardization of diagnosis and curative effect [S], Nanjing: publishing house of Nanjing University, 1994:26.), patient has paroxysmal or persistence waist angina abdominis, with frequent micturition, urgent micturition, dysurea symptom, visual hematuria, has sandstone in urine, routine urinalysis visible red cell, B ultrasonic, x-ray or renal phlebography can observe the position of calculus.
Selector close standard of stating urinary system calculus patient 80 example.Wherein man 60 example, female 20 example; Age 23-61 year, average (39 ± 2) year; Course of disease 1d-1, average 5.4 months ± 20.62d; All patients all make a definite diagnosis through x-ray or CT examination, wherein renal calculus 25 example, ureteral calculus 29 example, vesical calculus 21 example, compound calculus 5 example; Calculus diameter at 0.2-2cm, average (0.91 ± 0.35) cm.Be two groups by patient, be respectively treatment group 1 and treatment group 2, often group has 40 routine patients.Two groups of Genders, age, the course of disease, symptom there are no significant difference, have comparability (P > 0.05).
Treatment group 1 uses the decoction of preparation in embodiment 1 to treat, every day three times, oral 100 milliliters at every turn, continuously treatment 1 month.
Treatment group 2 uses the decoction of preparation in embodiment 2 to treat, every day three times, oral 100 milliliters at every turn, continuously treatment 1 month.
Statistical method
Utilize SPSS13.0 software to process and analyze to experimental data, measurement data is with mean ± standard deviation
represent, adopt t inspection, enumeration data adopts χ
2inspection, P < 0.05 represents that difference has statistical significance.
Efficacy determination
Cure: calculus is all discharged, the transference cure such as pain, frequent micturition, urine examination erythrocyte (-), B ultrasonic or x-ray etc. inspections have no calculus and levy;
Take a turn for the better: calculus major part is discharged, and residual calculus reduces or moves down, and the symptoms such as pain alleviate, urine examination erythrocyte (+), and B ultrasonic or x-ray etc. check visible residual stones;
Invalid: discharge without calculus, symptom does not improve, urine examination erythrocyte (++) is to (+++), and the B ultrasonic stone that comes to an end is unchanged.
Therapeutic outcome
For treatment group 1, cure 19 examples, take a turn for the better 15 examples, invalid 6 examples, and total effective rate is 85%; For treatment group 2, cure 23 examples, take a turn for the better 15 examples, and invalid 2 examples, total effective rate is 95%.Two groups of total effective rate comparing differences have statistical significance (P < 0.05).The effect for the treatment of group 2 is better than the effect for the treatment of group 1.Obvious untoward reaction is not all observed whole treatments period two groups.
Claims (6)
1. treat the Chinese medicine composition of calculus for one kind, it is characterized in that, it comprises the material of following weight portion: Radix Bupleuri 12 parts, Radix Paeoniae Rubra 12 parts, Fructus Aurantii Immaturus 12 parts, Herba Artemisiae Scopariae 24 parts, Radix Scutellariae 12 parts, Radix Salviae Miltiorrhizae 10 parts, Radix Et Rhizoma Rhei 10 parts, Radix Curcumae 12 parts, Herba Andrographis 15 parts, Herba Lysimachiae 30 parts, Fructus Gardeniae 10 parts, Endothelium Corneum Gigeriae Galli 12 parts, the Radix Aucklandiae 10 parts, 10 parts, Rhizoma Curcumae Longae, Pericarpium Citri Reticulatae 10 parts, Spora Lygodii 15 parts, Rhizoma Acori Graminei 15 parts, Fructus Liquidambaris 10 parts, Semen Plantaginis 15 parts, 10 parts, Talcum, Herba Dianthi 15 parts, Semen Vaccariae 20 parts, Rhizoma Corydalis 10 parts, Radix Achyranthis Bidentatae 12 parts, the Radix Paeoniae Alba 15 parts, Folium Pyrrosiae 15 parts, Semen Abutili 20 parts, Asteriscus Pseudosciaenae 15 parts, Fructus Aurantii 15 parts and 10 parts, Radix Glycyrrhizae.
2. the Chinese medicine composition for the treatment of calculus according to claim 1, it is characterized in that, it also comprises the material of following weight portion: Mahonia fortunei (Lindl.) Fedde 12 parts, the Radix Pulsatillae 18 parts, Cortex Alni sibiricae 15 parts, Amur Adonis Herb 12 parts, Herba malachii aquatici 13 parts, Herba Lysimachiae Insignis 15 parts, Herba Haloragidis Micranthae 10 parts, Caulis Bauhihiae Championii 10 parts, Radix Bauhiniae Hupehanae 10 parts, Herba oxalidis corymbosae 12 parts, Radix Phyllagathis fordii 12 parts and Rhizoma Tupistrae Chinensis 10 parts.
3. the Chinese medicine composition for the treatment of calculus according to claim 1 and 2, is characterized in that, described Chinese medicine composition can be tablet, dispersible tablet, capsule, unguentum or decoction.
4. the purposes of compositions in the Chinese medicine of preparation treatment calculus, it is characterized in that, described compositions comprises the material of following weight portion: Radix Bupleuri 12 parts, Radix Paeoniae Rubra 12 parts, Fructus Aurantii Immaturus 12 parts, Herba Artemisiae Scopariae 24 parts, Radix Scutellariae 12 parts, Radix Salviae Miltiorrhizae 10 parts, Radix Et Rhizoma Rhei 10 parts, Radix Curcumae 12 parts, Herba Andrographis 15 parts, Herba Lysimachiae 30 parts, Fructus Gardeniae 10 parts, Endothelium Corneum Gigeriae Galli 12 parts, the Radix Aucklandiae 10 parts, 10 parts, Rhizoma Curcumae Longae, Pericarpium Citri Reticulatae 10 parts, Spora Lygodii 15 parts, Rhizoma Acori Graminei 15 parts, Fructus Liquidambaris 10 parts, Semen Plantaginis 15 parts, 10 parts, Talcum, Herba Dianthi 15 parts, Semen Vaccariae 20 parts, Rhizoma Corydalis 10 parts, Radix Achyranthis Bidentatae 12 parts, the Radix Paeoniae Alba 15 parts, Folium Pyrrosiae 15 parts, Semen Abutili 20 parts, Asteriscus Pseudosciaenae 15 parts, Fructus Aurantii 15 parts and 10 parts, Radix Glycyrrhizae.
5. purposes according to claim 4, it is characterized in that, described compositions also comprises the material of following weight portion: Mahonia fortunei (Lindl.) Fedde 12 parts, the Radix Pulsatillae 18 parts, Cortex Alni sibiricae 15 parts, Amur Adonis Herb 12 parts, Herba malachii aquatici 13 parts, Herba Lysimachiae Insignis 15 parts, Herba Haloragidis Micranthae 10 parts, Caulis Bauhihiae Championii 10 parts, Radix Bauhiniae Hupehanae 10 parts, Herba oxalidis corymbosae 12 parts, Radix Phyllagathis fordii 12 parts and Rhizoma Tupistrae Chinensis 10 parts.
6. the purposes according to claim 4 or 5, is characterized in that, described Chinese medicine can be tablet, dispersible tablet, capsule, unguentum or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510536579.8A CN105169233B (en) | 2015-08-28 | 2015-08-28 | A kind of Chinese medicine composition for treating calculus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510536579.8A CN105169233B (en) | 2015-08-28 | 2015-08-28 | A kind of Chinese medicine composition for treating calculus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105169233A true CN105169233A (en) | 2015-12-23 |
| CN105169233B CN105169233B (en) | 2018-12-07 |
Family
ID=54891981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510536579.8A Expired - Fee Related CN105169233B (en) | 2015-08-28 | 2015-08-28 | A kind of Chinese medicine composition for treating calculus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105169233B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105497804A (en) * | 2016-01-14 | 2016-04-20 | 徐昌霞 | Traditional Chinese medicine decoction for treating lithangiuria |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1300609A (en) * | 2000-12-25 | 2001-06-27 | 郑阿权 | Medicine for treating calculus in urinary system |
| CN103223141A (en) * | 2012-01-31 | 2013-07-31 | 彭焕庭 | Stone-eliminating medicine powder |
| CN104042723A (en) * | 2013-03-12 | 2014-09-17 | 范德润 | Traditional Chinese medicine preparation for treating ureteral calculus |
-
2015
- 2015-08-28 CN CN201510536579.8A patent/CN105169233B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1300609A (en) * | 2000-12-25 | 2001-06-27 | 郑阿权 | Medicine for treating calculus in urinary system |
| CN103223141A (en) * | 2012-01-31 | 2013-07-31 | 彭焕庭 | Stone-eliminating medicine powder |
| CN104042723A (en) * | 2013-03-12 | 2014-09-17 | 范德润 | Traditional Chinese medicine preparation for treating ureteral calculus |
Non-Patent Citations (1)
| Title |
|---|
| 郝永鹏: "治疗肾结石方一则", 《中国民间疗法》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105497804A (en) * | 2016-01-14 | 2016-04-20 | 徐昌霞 | Traditional Chinese medicine decoction for treating lithangiuria |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105169233B (en) | 2018-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102552580B (en) | Formula of orally-taken drug for treating lithangiuria and difficult urination and preparation technology of drug | |
| CN103919940A (en) | Chinese medicinal composition for treating hemorrhoid | |
| CN105902906A (en) | Traditional Chinese medicine composition for treating wind-cold-type cold and cough and preparation method thereof | |
| CN101007151A (en) | Traditional Chinese medicine and its preparation for treating chronic nephritis | |
| CN101804189B (en) | Drug for treating primary dysmenorrhea | |
| CN100548363C (en) | Medicine of treatment benign prostate hyperplasia and preparation method thereof | |
| CN105169233A (en) | Traditional Chinese medicine composition for treating calculi | |
| CN104587267A (en) | Traditional Chinese medicine composition for treating psoriasis | |
| CN104257800A (en) | Medicament for treating acnes | |
| CN104491459A (en) | Traditional Chinese medicine composition for treating tumors | |
| CN104225346A (en) | Chinese herbal preparation for treating hematuria and preparation method thereof | |
| CN104013704B (en) | Pharmaceutical composition for treating chronic pelvic inflammatory disease and preparation method of composition | |
| CN103330897B (en) | Pharmaceutical composition for treating renal and ureteral calculus | |
| CN101829188B (en) | Medicament for treating urinary infection and lithiasis | |
| CN104800675A (en) | Medicament for treating active ulcerative colitis | |
| CN104587389A (en) | Traditional Chinese medicine composition for treating neck shoulder pain and lumbocrural pain | |
| CN116726083B (en) | Traditional Chinese medicine composition for treating chronic prostatitis | |
| CN104258175A (en) | Traditional Chinese medicine for treating kidney calculi and preparation method thereof | |
| CN103860786A (en) | Medicine for treating puerperal fever | |
| CN103830646B (en) | A kind of preparation method of the pharmaceutical composition treating kidney or ureter stone | |
| CN115089674B (en) | Traditional Chinese medicine composition for preventing and treating gout by melting urate calculi, and preparation method and application thereof | |
| CN103585471B (en) | Traditional Chinese medicine composition for treating thrombocytopenia | |
| CN1308031C (en) | Chinese medicine composition for treating biliary tract disease, preparing method and use | |
| CN102641446A (en) | Chinese medicament for treating prostatic diseases and preparation method thereof | |
| CN102225154B (en) | Medicament composition for treating pulmonary fibrosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20181207 Termination date: 20210828 |